Toggle Mobile Menu

Explore our impact areas and learn about our grantees.

Early Childhood Development Medical Research & Talent K-12 Education Environmental Innovation Data Science Education Collaborative Philanthropy
Back

Updates

Filter Updates By

All

Collaborative Philanthropy

Data Science Education

Early Childhood Development

Environmental Innovation

K-12 Education

Medical Research & Talent

Valhalla Update

Valhalla Update|May 1, 2020

Valhalla Foundation Grants $15.6 Million to Organizations in Response to COVID-19

In March 2020, as COVID-19 began spreading rapidly, it became clear that the impacts of the pandemic would be severe and particularly devastating on the disadvantaged populations we seek to serve through our work at Valhalla Foundation. In response, we committed $15.6M to 14 organizations over the first few months of the pandemic.

Medical Research & Talent|March 28, 2017

F.D.A. Approves New Drug to Treat Severe Multiple Sclerosis

The drug, ocrelizumab, is one of three new "B-cell" therapies to treat MS that have proven to be extremely effective in preventing MS relapses.